CROs/Service Providers

Midwest Melanoma, Accelovance partner

Friday, September 18, 2015

Accelovance, a Rockville, Md.-based global CRO focusing in oncology, vaccines and general medicine, and the Midwest Melanoma Partnership (MMP), a nonprofit organization dedicated to improving therapies for patients diagnosed with malignant melanoma, have entered into a strategic alliance to enhance the research and advancement of treatment options for patients suffering from melanoma.

[Read More]

Survey: Jump in CRO use of eTMF applications

Thursday, September 17, 2015

There has been a significant increase in the number of CROs using electronic trial master file (eTMF) applications from just one year ago, according to a report from Veeva Systems, a San Francisco Bay Area-based provider of cloud-based software. The “Veeva 2015 Paperless TMF Survey: Annual CRO Report” was a global study of TMF owners that found 38% of CROs surveyed now use eTMF applications versus just 21% in 2014. A number of benefits are prompting CROs’ adoption of eTMF technology. More than half (58%) say faster study startup is a key driver, while 50% cite cost savings.

[Read More]

Abzena acquires PacificGMP

Wednesday, September 16, 2015

Abzena, a U.K.-based life sciences company providing services and technologies to enable better biopharmaceutical products, has acquired PacificGMP, a privately held contract biopharmaceutical development and manufacturing company (CDMO) based in San Diego.

[Read More]

PRA expands Pennsylvania workforce

Monday, September 14, 2015

PRA Health Sciences (PRA), a global CRO based in Raleigh, N.C., is expanding its presence in Pennsylvania. Employees recently relocated from the company’s Horsham and Fort Washington facilities to PRA’s new modern office space in Blue Bell, now the company’s largest office worldwide. PRA currently has more than 1,000 employees in Pennsylvania and is looking to add additional staff.

[Read More]

Certara, Paidion Research partner on pediatric drug development

Friday, September 11, 2015

Certara, a global biosimulation technology-enabled drug development company, and Paidion Research, a Durham, N.C.-based pediatric CRO, have partnered to promote more efficient and reliable drug development for pediatric patients. The partnership harnesses Certara’s biosimulation (modeling and simulation) and regulatory writing capabilities with Paidion’s regulatory strategy and pediatric clinical trial management expertise to address the critical challenges of bringing new therapies to children.

[Read More]

Rho, NIAD partner

Thursday, September 10, 2015

Rho, a privately held CRO based in Chapel Hill, N.C., has been awarded a new cooperative agreement to provide statistical and clinical coordinating services to the Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID). The CRO will provide these services for DAIT’s large clinical research consortia in the areas of asthma and allergic diseases, autoimmune diseases and transplantation.

[Read More]

BTE launches Research Services

Thursday, September 10, 2015

BTE, a global innovator in objective human performance evaluation and rehabilitation technology, has launched its new Research Services group. For over 35 years, BTE has pioneered evidence-based systems to support quantitative muscle testing (QMT) for employers, physicians and other healthcare providers. In recent months, BTE has expanded into supporting the needs of drug development professionals and research scientists with our knowhow and measurement technologies. The Research Services group leverages the technical expertise and scientific leadership already present in BTE’s Rehabilitation Equipment and Workforce Solutions business units.

[Read More]